generics

News

European Medicines Agency Doesn't Expect Number of New Drug Filings to Grow in 2011

News

Severin Schwan of Roche Sees Generic Companies and Innovators As Winners

News

Penicillin: Dr. Reddy's Buys Glaxo's U.S. Business

News

Biosimilar Antibodies: EU Likely to Be Cautious

News

Bristol-Myers, Lilly Win Major Drug Patent Rulings

News

Teva to Buy Merck KGaA's Women's Health Unit

News

EU To Seek Details Of Deals Delaying Generic Drugs

News

Roche Maintains Focus as Industry Faces Cutbacks

News

Head of U.S. Generic Drugs Association to Step Down

News

Teva Wins U.S. Approval for Generics Of Merck Drugs

News

Hungary's Richter, Indian Astron Research to Develop Generics

News

Planned EU Deal Not to Hit Indian Generic Drug Industry

News

Pfizer Faces Hefty Price To Secure Stada

News

Generic Deals May Still Hold Appeal for Pfizer

News

Ratiopharm Fields Decisive Takeover Bids

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Enigma Marketing Research

F. Hoffmann-La Roche Ltd

Camelot Management Consultants AG

Fitch Ratings

Deutsche Post DHL

SchüllerConsulting

Thomson Reuters

Arthur D. Little

GlobalData

Porsche Consulting

CMS Advisors GmbH & Co. KG

Saltigo GmbH

ARC Advisory Group GmbH & Co KG

Codexis

FDA Smart

Camelot Management Consultants AG

generics

Teva Q1 Profit Up On Higher European Sales

Teva To Buy Cephalon For $6.8 Billion

Sun Pharma To Sell Some Merck Diabetes Drugs In India

U.S. Drug Prices Outstrip Other Medical Costs

Teva's Shlomo Yanai Sees Benefit From Obama Health Reforms

The Pharmaceutical Industry On The Move

Patent Cliff To Intensify in the U.S. in 2011

European Medicines Agency Doesn't Expect Number of New Drug Filings to Grow in 2011

Severin Schwan of Roche Sees Generic Companies and Innovators As Winners

Penicillin: Dr. Reddy's Buys Glaxo's U.S. Business

Biosimilar Antibodies: EU Likely to Be Cautious

Bristol-Myers, Lilly Win Major Drug Patent Rulings

Teva to Buy Merck KGaA's Women's Health Unit

EU To Seek Details Of Deals Delaying Generic Drugs

Roche Maintains Focus as Industry Faces Cutbacks

Head of U.S. Generic Drugs Association to Step Down

Teva Wins U.S. Approval for Generics Of Merck Drugs

Hungary's Richter, Indian Astron Research to Develop Generics

Planned EU Deal Not to Hit Indian Generic Drug Industry

Pfizer Faces Hefty Price To Secure Stada

Generic Deals May Still Hold Appeal for Pfizer

Ratiopharm Fields Decisive Takeover Bids

Top-Feature

Upcoming Virtual Events

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Siemens Joins the Global Impact Coalition

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

ADCs for Precision Cancer Therapy

generics

Top-Feature

Upcoming Virtual Events

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Siemens Joins the Global Impact Coalition

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

Newsletter & e-edition